Cerity Partners’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.5K | Buy |
36,393
+1,828
| +5% | +$1.48K | ﹤0.01% | 2589 |
|
|
2025
Q1 | $26.5K | Buy |
34,565
+1,688
| +5% | +$1.3K | ﹤0.01% | 2427 |
|
|
2024
Q4 | $68.1K | Buy |
32,877
+2
| +0% | +$4 | ﹤0.01% | 2369 |
|
|
2024
Q3 | $68.1K | Buy |
+32,875
| New | +$68.1K | ﹤0.01% | 2462 |
|
|
2024
Q2 | – | Sell |
-32,500
| Closed | -$154K | – | 2372 |
|
|
2024
Q1 | $154K | Buy |
+32,500
| New | +$154K | ﹤0.01% | 2155 |
|